Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Comment by stanleyon Mar 18, 2013 8:35am
182 Views
Post# 21144408

RE: Brigus Shares Current Trading - After Close

RE: Brigus Shares Current Trading - After Close

Kewl2:

[S] Many posters speculate that the POG is being suppressed as an inflation fighting tactic. This is negatively impacting the BRD pps. Can the paper manipulaters contain this volatility?

Also noteworthy as posted on this board and is the HUGE POTENTIAL rammifications of the 9.9% tax on bank accounts over 100k in Cyprus. This would normally be met by a "what odds" from the masses; but throw in an alleged Russian/KGB use of Cyprus of for "investment purposes" and we have a POTENTIAL event on our hands. Again the SSL website has some links worth skimming.

 

Just look at the Kitco Charts to see this volatility of world events is doing to the POG.

 

https://www.kitco.com/charts/livegold.html

 

On Sandstorm's Website on Mar 16th there is an excellent post wrt the nefarious activity of Coffintrader who was "nailed" by the Alberta Securities Commission for market manipulation. Point being, many of his techniques appear to be used by the multiple accounts in play here. While his trades were placed manually; wrt BRD high speed computers are used to do their dirty deeds.

 

BWDIK? BRD is moving from start-up to steady state production. The company is close to putting the stamp on Q1's production. The POG used in their Winter projection is $1,600 (above the Q's daily weighted average).

 

https://www.brigusgold.com/presentations.aspx?iid=4288058

 

The Cyprus "crisis" cited above could help BRD as it will help to send/keep the POG over the $1 600 projected by BRD.

 

Cheers

Stanley

Bullboard Posts